Literature DB >> 11901104

Predicting evolutionary potential: in vitro evolution accurately reproduces natural evolution of the tem beta-lactamase.

Miriam Barlow1, Barry G Hall.   

Abstract

To evaluate the validity of our in vitro evolution method as a model for natural evolutionary processes, the TEM-1 beta-lactamase gene was evolved in vitro and was selected for increased resistance to cefotaxime, cefuroxime, ceftazadime, and aztreonam, i.e., the "extended-spectrum" phenotype. The amino acid substitutions recovered in 10 independent in vitro evolvants were compared with the amino acid substitutions in the naturally occurring extended-spectrum TEM alleles. Of the nine substitutions that have arisen multiple times in naturally occurring extended-spectrum TEM alleles, seven were recovered multiple times in vitro. We take this result as evidence that our in vitro evolution technique accurately mimics natural evolution and can therefore be used to predict the results of natural evolutionary processes. Additionally, our results predict that a phenotype not yet observed among TEM beta-lactamases in nature-resistance to cefepime-is likely to arise in nature.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11901104      PMCID: PMC1462021     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  30 in total

1.  Improved green fluorescent protein by molecular evolution using DNA shuffling.

Authors:  A Crameri; E A Whitehorn; E Tate; W P Stemmer
Journal:  Nat Biotechnol       Date:  1996-03       Impact factor: 54.908

Review 2.  Catalytic properties of class A beta-lactamases: efficiency and diversity.

Authors:  A Matagne; J Lamotte-Brasseur; J M Frère
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

3.  Probability distribution of molecular evolutionary trees: a new method of phylogenetic inference.

Authors:  B Rannala; Z Yang
Journal:  J Mol Evol       Date:  1996-09       Impact factor: 2.395

4.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.

Authors:  J D Thompson; T J Gibson; F Plewniak; F Jeanmougin; D G Higgins
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

5.  Generation of large libraries of random mutants in Bacillus subtilis by PCR-based plasmid multimerization.

Authors:  S Shafikhani; R A Siegel; E Ferrari; V Schellenberger
Journal:  Biotechniques       Date:  1997-08       Impact factor: 1.993

Review 6.  Optimizing industrial enzymes by directed evolution.

Authors:  F H Arnold; J C Moore
Journal:  Adv Biochem Eng Biotechnol       Date:  1997       Impact factor: 2.635

7.  TEM-72, a new extended-spectrum beta-lactamase detected in Proteus mirabilis and Morganella morganii in Italy.

Authors:  M Perilli; B Segatore; M R de Massis; M L Riccio; C Bianchi; A Zollo; G M Rossolini; G Amicosante
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 8.  Are all beta-lactams created equal?

Authors:  D M Livermore
Journal:  Scand J Infect Dis Suppl       Date:  1996

9.  Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan.

Authors:  J J Yan; S M Wu; S H Tsai; J J Wu; I J Su
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

10.  Directed evolution of a para-nitrobenzyl esterase for aqueous-organic solvents.

Authors:  J C Moore; F H Arnold
Journal:  Nat Biotechnol       Date:  1996-04       Impact factor: 54.908

View more
  49 in total

1.  Experimental prediction of the natural evolution of antibiotic resistance.

Authors:  Miriam Barlow; Barry G Hall
Journal:  Genetics       Date:  2003-04       Impact factor: 4.562

2.  Predicting evolution by in vitro evolution requires determining evolutionary pathways.

Authors:  Barry G Hall
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

3.  Experimental prediction of the evolution of cefepime resistance from the CMY-2 AmpC beta-lactamase.

Authors:  Miriam Barlow; Barry G Hall
Journal:  Genetics       Date:  2003-05       Impact factor: 4.562

4.  In vitro evolution predicts that the IMP-1 metallo-beta-lactamase does not have the potential to evolve increased activity against imipenem.

Authors:  Barry G Hall
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

5.  Bridging the gaps in design methodologies by evolutionary optimization of the stability and proficiency of designed Kemp eliminase KE59.

Authors:  Olga Khersonsky; Gert Kiss; Daniela Röthlisberger; Orly Dym; Shira Albeck; Kendall N Houk; David Baker; Dan S Tawfik
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-08       Impact factor: 11.205

6.  How mutational epistasis impairs predictability in protein evolution and design.

Authors:  Charlotte M Miton; Nobuhiko Tokuriki
Journal:  Protein Sci       Date:  2016-01-22       Impact factor: 6.725

7.  Experimental prediction of the evolution of ceftazidime resistance in the CTX-M-2 extended-spectrum beta-lactamase.

Authors:  Kerry J Welsh; Miriam Barlow; Fred C Tenover; James W Biddle; J Kamile Rasheed; Leigh Ann Clark; John E McGowan
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

8.  Unexpected enzyme TEM-126: role of mutation Asp179Glu.

Authors:  J Delmas; F Robin; F Bittar; C Chanal; R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

Review 9.  Parallel genotypic adaptation: when evolution repeats itself.

Authors:  Troy E Wood; John M Burke; Loren H Rieseberg
Journal:  Genetica       Date:  2005-02       Impact factor: 1.082

10.  Recombination and selection can remove blaTEM alleles from bacterial populations.

Authors:  Joanna E Mroczkowska; Miriam Barlow
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.